Our experienced technical and quality staff have worked together for more than two decades offering CGMP/GLP compliant molecular biology and microbiology assays to support regulatory submissions.
XUENING (JAMES) HUANG, PhDCEO/CTO, Co-founder
Dr. Huang has extensive management experiences in the biotechnology service industry. Before he joined Avance Biosciences, he held senior management positions in several biotechnology service companies. He was the Site Manager and Director of Operations at Lark/Cogenics, where he helped to engineered a company restructure and led the site to a successful turn-around in business performance. Dr. Huang is a trained chemist and has an extensive track record of process development and improvement.
DAVID WALL, PhDSenior VP of Quality, Co-founder
Dr. Wall brings more than 20 years of experience in the molecular biology and microbiology industry and has a profound knowledge of both GxP quality compliance and the biological sciences. Graduating from Texas A&M University with a Bachelor’s of Science in Animal Science and a Doctorate in Genetics, Dr. Wall began his career in the genotyping industry. From there, he worked for 15 years at Lark/Cogenics, where he served in multiple key positions such as Study Director, Laboratory Director, and Director of Quality and managed numerous large-scale genomic testing projects for major pharmaceutical companies around the world. During his career, he has hosted over 300 customer audits and led in three successful FDA inspections. In addition to his role as the company’s VP of Quality, Dr. Wall provides leadership in the areas of finance, HR and facilities management.
LI (KIMBERLY) LI, PhDSenior VP of Strategic Development, Co-founder
Dr. Li is a Co-founder of Avance Biosciences Inc. and the senior Vice President of Strategic Development. Previously, she held positions of Vice President of Operations, Vice President of Project Management at Avance Biosciences from 2011 to 2021. Prior to joining Avance Biosciences, she served as laboratory director and study director at Lark/Cogenics. In the past 20 years, she has managed many GLP preclinical and clinical projects in support of clients’ drug discovery and development studies, safety and toxicology studies, as well as GMP manufactured biologics quality control testing.
Christopher A. Seid, PhDVP of Strategic Development
Dr. Seid has over twenty-five years of experience in the Biotechnology field which have included various positions ranging from basic research to process development, manufacturing, and molecular services. Before joining Avance Biosciences, Dr. Seid was Director of Upstream Process Development for Tropical Medicine Research in the section of Pediatric Tropical Medicine at Baylor College of Medicine. Prior to BCM, Dr. Seid was Study Director for Beckman Coulter Genomics, Inc., a molecular and genomic services provider to the Biotechnology, Academic, and Pharmaceutical community. Other positions held include Technical Manager of the Molecular Genomics Bioproduction Department at the American Type Culture Collection and Senior Scientist at Regeneration Technologies Inc., a tissue engineering company located in Alachua, Florida. Dr. Seid received his B.S. in Biology in from Stephen F. Austin State University and his Ph.D. in Cellular & Developmental Biology from the University of Houston.
Cal FrobergSenior VP of Sales & Marketing
Mr. Froberg has worked in the life science tools and services industry for over 20 years serving in a variety of roles from product management to sales channel/distribution management to senior level positions in sales & marketing and operations. He has worked for some of the leaders in the industry including Sigma Aldrich and VWR Scientific, as well as with leading genomic services companies. Additionally, Mr. Froberg founded Scientific Sales Solutions which helped sales organizations connect to and develop business with life science research organizations in academia, government and industry. Prior to his role as VP of Sales & Marketing, Mr. Froberg worked with Avance Biosciences for several years as a consultant assisting with in the area of sales, marketing and strategic operations. Mr. Froberg has a Bachelor of Science degree from Texas A&M University.
James Frost IIIVP of IT & Engineering
Mr. Frost has over 30 years of executive management experience in the biotechnology service and tool industry and is the founder of two biotech companies: Genosys Biotechnologies, Inc. (sold to Sigma Aldrich) and BioTx Automation, Inc. He has spent his entire career devoted to making processes more efficient. Most recently, as a Director of Lab and Automation at Quest Diagnostics, he led his development team’s successful completion, validation and implementation of a mag bead-based cell isolation process for use with Oxford’s T-SPOT.TB test using a Lynx liquid handler. This process is currently in use at the world’s largest Tuberculosis testing lab in Memphis TN. Throughout his career, he has improved manufacturing processes using innovative thought.
When you partner with Avance Biosciences, you gain a CRO partner that is creative, collaborative and dedicated to sound science with a focus on the regulatory requirements our partners require. Contact our technical staff to discuss how we can support you in your project!
Dedication to Quality
The Avance Biosciences team is committed to strict adherence to CGMP and GLP regulations enacted by the US, European, Japanese, and other international regulatory agencies.
Our team has extensive knowledge and experience working with scientists, QA/QC professionals, and project managers from over 100 pharmaceutical and biotechnology companies and organizations throughout the world.
Transparency and integrity are two of our core values. Our well-trained, friendly, and professional study directors and project managers strive to complete your projects on-time with open communication channels and to your specifications.
Avance Biosciences’ GLP/GMP compliant genomic and microbial assays make use of the advanced technologies including real-time PCR, ddPCR, Sanger sequencing, next-gen sequencing, Southern blot, and more.